Acalabrutinib is indicated for:
Irrespective of gender only Adults (18 years old or older)
Acalabrutinib is indicated for the treatment of adult patients with small lymphocytic lymphoma (SLL).
For this indication, the medical literature mentions below treatments (click for details):
Irrespective of gender only Adults (18 years old or older)
Acalabrutinib is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.
For this indication, the medical literature mentions below treatments (click for details):
Irrespective of gender only Adults (18 years old or older)
Acalabrutinib is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL).
For this indication, the medical literature mentions below treatments (click for details):
Active ingredient Acalabrutinib is contraindicated in the following cases: